By temporally dissecting mutations, we emphasized the significance of two cancer pathways, RTK-RAS and histone modification (especially KMT2D, KDM6 A and CREBBP), in the initiation of NMIBC due to the high enrichment in early mutations and high early selection preference, respectively. The gene discussed is CREBBP; the disease is cancer.